92 related articles for article (PubMed ID: 23474898)
1. Biaryl tetrazolyl ureas as inhibitors of endocannabinoid metabolism: modulation at the N-portion and distal phenyl ring.
Ortar G; Morera E; De Petrocellis L; Ligresti A; Schiano Moriello A; Morera L; Nalli M; Ragno R; Pirolli A; Di Marzo V
Eur J Med Chem; 2013 May; 63():118-32. PubMed ID: 23474898
[TBL] [Abstract][Full Text] [Related]
2. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Holtfrerich A; Hanekamp W; Lehr M
Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels.
Ortar G; De Petrocellis L; Moriello AS; Allarà M; Morera E; Nalli M; Di Marzo V
Bioorg Med Chem Lett; 2013 Jan; 23(1):138-42. PubMed ID: 23206861
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
Morera L; Labar G; Ortar G; Lambert DM
Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
[TBL] [Abstract][Full Text] [Related]
5. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
[TBL] [Abstract][Full Text] [Related]
6. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597).
Niforatos W; Zhang XF; Lake MR; Walter KA; Neelands T; Holzman TF; Scott VE; Faltynek CR; Moreland RB; Chen J
Mol Pharmacol; 2007 May; 71(5):1209-16. PubMed ID: 17314320
[TBL] [Abstract][Full Text] [Related]
7. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
[TBL] [Abstract][Full Text] [Related]
8. Discovery of non-electrophilic capsaicinoid-type TRPA1 ligands.
Del Prete D; Caprioglio D; Appendino G; Minassi A; Schiano-Moriello A; Di Marzo V; De Petrocellis L
Bioorg Med Chem Lett; 2015 Mar; 25(5):1009-11. PubMed ID: 25666822
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
Morera E; De Petrocellis L; Morera L; Moriello AS; Ligresti A; Nalli M; Woodward DF; Di Marzo V; Ortar G
Bioorg Med Chem Lett; 2009 Dec; 19(23):6806-9. PubMed ID: 19875281
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Isatin-Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
Jaiswal S; Ayyannan SR
ChemMedChem; 2022 Jan; 17(1):e202100559. PubMed ID: 34637598
[TBL] [Abstract][Full Text] [Related]
11. 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.
Granchi C; Rizzolio F; Bordoni V; Caligiuri I; Manera C; Macchia M; Minutolo F; Martinelli A; Giordano A; Tuccinardi T
J Enzyme Inhib Med Chem; 2016; 31(1):137-46. PubMed ID: 25669350
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of a new series of reversible dual monoacylglycerol lipase/fatty acid amide hydrolase inhibitors.
Cisneros JA; Björklund E; González-Gil I; Hu Y; Canales A; Medrano FJ; Romero A; Ortega-Gutiérrez S; Fowler CJ; López-Rodríguez ML
J Med Chem; 2012 Jan; 55(2):824-36. PubMed ID: 22185522
[TBL] [Abstract][Full Text] [Related]
13. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
Petrosino S; Di Marzo V
Curr Opin Investig Drugs; 2010 Jan; 11(1):51-62. PubMed ID: 20047159
[TBL] [Abstract][Full Text] [Related]
14. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
[TBL] [Abstract][Full Text] [Related]
15. The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.
Minkkilä A; Myllymäki MJ; Saario SM; Castillo-Melendez JA; Koskinen AM; Fowler CJ; Leppänen J; Nevalainen T
Eur J Med Chem; 2009 Jul; 44(7):2994-3008. PubMed ID: 19232787
[TBL] [Abstract][Full Text] [Related]
16. The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review.
Fowler CJ
Handb Exp Pharmacol; 2015; 231():95-128. PubMed ID: 26408159
[TBL] [Abstract][Full Text] [Related]
17. Arylboronic acids as dual-action FAAH and TRPV1 ligands.
Morera E; Di Marzo V; Monti L; Allarà M; Schiano Moriello A; Nalli M; Ortar G; De Petrocellis L
Bioorg Med Chem Lett; 2016 Mar; 26(5):1401-5. PubMed ID: 26850005
[TBL] [Abstract][Full Text] [Related]
18. Loratadine analogues as MAGL inhibitors.
Patel JZ; Ahenkorah S; Vaara M; Staszewski M; Adams Y; Laitinen T; Navia-Paldanius D; Parkkari T; Savinainen JR; Walczyński K; Laitinen JT; Nevalainen TJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1436-42. PubMed ID: 25752982
[TBL] [Abstract][Full Text] [Related]
19. The design, synthesis and biological evaluation of novel URB602 analogues as potential monoacylglycerol lipase inhibitors.
Szabo M; Agostino M; Malone DT; Yuriev E; Capuano B
Bioorg Med Chem Lett; 2011 Nov; 21(22):6782-7. PubMed ID: 21982493
[TBL] [Abstract][Full Text] [Related]
20. Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.
Myllymäki MJ; Käsnänen H; Kataja AO; Lahtela-Kakkonen M; Saario SM; Poso A; Koskinen AM
Eur J Med Chem; 2009 Oct; 44(10):4179-91. PubMed ID: 19539407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
